Mario Felice Tecce

Prof. Dr. Mario Felice Tecce

Biochemistry, Department of Pharmacy, University of Salerno, 84084 Fisciano, Italy
orcid

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2017 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
TRTania Rescigno
Tania Rescigno
ACAnna Capasso
Anna Capasso
Mario Felice TecceMario Felice Tecce
Mario Felice Tecce

29 January 2015 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
MRMaria Caterina De Rosa
Maria Caterina De Rosa
MCMariella Caputo
Mariella Caputo
HZHylde Zirpoli
Hylde Zirpoli
TRTania Rescigno
Tania Rescigno
RTRoberta Tarallo
Roberta Tarallo
Mario Felice TecceMario Felice Tecce
Mario Felice Tecce


1 May 1994 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JTJ L Telford
J L Telford
PGP Ghiara
P Ghiara
MDM Dell'ORco
M Dell'ORco
MCM Comanducci
M Comanducci
DBD Burroni
D Burroni
ZXZ Xiang
Z Xiang
The gram negative, microaerophilic bacterium Helicobacter pylori colonizes the human gastric mucosa and establishes a chronic infection that is tightly associated with atrophic gastritis, peptic ulcer, and gastric carcinoma. Cloning of the H. pylori cytotoxin gene shows that the protein is synthesized as a 140-kD precursor that is processed to a 94-kD fully active toxin. Oral administration to mice of the purified 94-kD protein caused ulceration and gastric lesions that bear some similarities to the pathology observed in humans. The cloning of the cytotoxin gene and the development of a mouse model of human gastric disease will provide the basis for the understanding of H. pylori pathogenesis and the development of therapeutics and vaccines.

15 July 1998 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli
Giovanni VigliottaGiovanni Vigliotta
Giovanni Vigliotta
CICarlo Iavarone
Carlo Iavarone
MCMatilde Caruso
Matilde Caruso
Carlo Gabriele TocchettiCarlo Gabriele Tocchetti
Carlo Gabriele Tocchetti
FBFrancesco Beguinot
Francesco Beguinot
We have used differential display to identify genes whose expression is altered in type 2 diabetes thus contributing to its pathogenesis. One mRNA is overexpressed in fibroblasts from type 2 diabetics compared with non‐diabetic individuals, as well as in skeletal muscle and adipose tissues, two major sites of insulin resistance in type 2 diabetes. The levels of the protein encoded by this mRNA are also elevated in type 2 diabetic tissues; thus, we named it PED for phosphoprotein enriched in diabetes. PED cloning shows that it encodes a 15 kDa phosphoprotein identical to the protein kinase C (PKC) substrate PEA‐15. The PED gene maps on human chromosome 1q21–22. Transfection of PED/PEA‐15 in differentiating L6 skeletal muscle cells increases the content of Glut1 transporters on the plasma membrane and inhibits insulin‐stimulated glucose transport and cell‐surface recruitment of Glut4, the major insulin‐sensitive glucose transporter. These effects of PED overexpression are reversed by blocking PKC activity. Overexpression of the PED/PEA‐15 gene may contribute to insulin resistance in glucose uptake in type 2 diabetes.